BlackRock
CLBT icon

BlackRock’s Cellebrite CLBT Stock Holding History

BlackRock’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83M Buy
5,684,040
+2,344,395
+70% +$31M ﹤0.01% 2337
2026
Q1 		$46M Sell
3,339,645
-989,268
-23% -$14.9M ﹤0.01% 2560
2025
Q4 		$78.1M Buy
4,328,913
+597,369
+16% +$10.7M ﹤0.01% 2248
2025
Q3 		$69.1M Buy
3,731,544
+791,588
+27% +$12.4M ﹤0.01% 2309
2025
Q2 		$47M Buy
2,939,956
+277,894
+10% +$4.95M ﹤0.01% 2485
2025
Q1 		$51.7M Buy
2,662,062
+598,551
+29% +$12.6M ﹤0.01% 2360
2024
Q4 		$45.5M Buy
2,063,511
+342,215
+20% +$6.59M ﹤0.01% 2500
2024
Q3 		$29M Sell
1,721,296
-170,313
-9% -$2.53M ﹤0.01% 2804
2024
Q2 		$22.6M Buy
1,891,609
+413,885
+28% +$4.62M ﹤0.01% 2908
2024
Q1 		$16.4M Buy
1,477,724
+361,163
+32% +$3.69M ﹤0.01% 3100
2023
Q4 		$9.67M Buy
1,116,561
+433,616
+63% +$3.37M ﹤0.01% 3414
2023
Q3 		$5.22M Buy
682,945
+206,103
+43% +$1.55M ﹤0.01% 3644
2023
Q2 		$3.43M Sell
476,842
-3,175
-0.7% -$18.5K ﹤0.01% 3857
2023
Q1 		$2.92M Buy
480,017
+146,057
+44% +$792K ﹤0.01% 3874
2022
Q4 		$1.46M Sell
333,960
-88,640
-21% -$396K ﹤0.01% 4269
2022
Q3 		$1.66M Buy
422,600
+211
+0% +$1.06K ﹤0.01% 4284
2022
Q2 		$2.15M Sell
422,389
-15,136
-3% -$78.7K ﹤0.01% 4225
2022
Q1 		$2.8M Buy
437,525
+217
+0% +$1.44K ﹤0.01% 4249
2021
Q4 		$3.51M Buy
+437,308
New +$4.12M ﹤0.01% 4151

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock's CLBT Position: Q2 2026 in Review

BlackRock increased its Cellebrite (CLBT) stake by 70% in Q2 2026, buying an estimated $31M and bringing the position to 5,684,040 shares worth $83M. The position accounts for ﹤0.01% of the portfolio, ranked #2337.

BlackRock first reported a position in CLBT in Q4 2021 and has held it in 19 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • BlackRock held 5,684,040 shares of Cellebrite worth $83M as of Q2 2026.
  • BlackRock bought 2,344,395 Cellebrite shares in Q2 2026, an estimated $31M.
  • Cellebrite made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2337 holding.
  • BlackRock first reported a position in Cellebrite in Q4 2021 and has held it in 19 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.